Eden Biologics, Inc.

Lupin , which had joined hands with Yoshindo in 2014 for a biosimilars joint venture in Japan, has chosen to go with another familiar face, the I’Rom Group, to develop and commercialize a denosumab bi

Lupin Limited , which had joined hands with Yoshindo Inc. in 2014 for a biosimilars joint venture in Japan, has chosen to go with another familiar face, the I’Rom Group, to develop and commercialize a

Eden Biologics, Inc. CEO and director Steven Lee has announced that the company has completed a deal for its contract development and manufacturing operations unit to be acquired by Bora Pharmaceutic

Shanghai Henlius Biotech ’s co-founder Scott Liu, who held the positions of president and CEO at Henlius before stepping down in September 2020 “due to a change in personal business priorities”, has j